Fcpm Iii Services B.V. Dyne Therapeutics, Inc. Transaction History
Fcpm Iii Services B.V.
- $582 Billion
- Q3 2024
A detailed history of Fcpm Iii Services B.V. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 5,954,069 shares of DYN stock, worth $143 Million. This represents 36.73% of its overall portfolio holdings.
Number of Shares
5,954,069
Previous 7,845,364
24.11%
Holding current value
$143 Million
Previous $277 Billion
22.75%
% of portfolio
36.73%
Previous 40.83%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
209Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$192 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$177 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$165 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$164 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$163 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.24B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...